<DOC>
	<DOCNO>NCT01911767</DOCNO>
	<brief_summary>The primary objective study prospectively evaluate pregnancy outcome woman multiple sclerosis expose Registry-specified Biogen Multiple Sclerosis product eligibility window product . The Registry-specified Biogen MS product study dimethyl fumarate , Pegylated human interferon beta-1a , Dalclizumab High Yield Process ( DAC HYP ) .</brief_summary>
	<brief_title>Biogen Multiple Sclerosis Pregnancy Exposure Registry</brief_title>
	<detailed_description>The Biogen Multiple Sclerosis Pregnancy Exposure Registry prospective , observational registry design evaluate pregnancy outcome woman multiple sclerosis ( MS ) expose Registry-specified Biogen Multiple Sclerosis product eligibility window product . Women childbearing potential considerable segment patient population affect MS likely expose Registry-specified Biogen MS product around time conception pregnancy . Biogen complete pregnancy registry Avonex Tysabri ; however , formal study pregnant woman conduct . Therefore , important evaluate , global Pregnancy Registry , exposure market Biogen MS product specify Pregnancy Registry may affect pregnancy infant outcome . Data collect prospective pregnancy ( i.e . enrollment prior knowledge outcome ) time enrollment , 6 7 month gestation , approximately 4,12 , 52 week estimate date delivery . The prevalence spontaneous abortion , birth defect , pregnancy infant outcome calculate compare background rate external source European Surveillance Congenital Anomalies .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<criteria>Key Patient consent Patient diagnosis MS . Documentation patient expose Registryspecified Biogen MS product eligibility window product . DMF : Exposure since first day last menstrual period ( LMP ) prior conception time pregnancy . Peginterferon beta1a : Exposure since 14 day prior first day LMP prior conception time pregnancy . DAC HYP : Exposure since 90 day prior first day LMP prior conception time pregnancy Patient agree sign Release Medical Information Form , thereby permit Registry contact health care provider ( HCP ( ) ) pediatric HCP medical information . Key The outcome pregnancy ( i.e. , pregnancy loss live birth ) must know time enrollment . NOTE : Other protocol define Inclusion/ Exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>